Dolat Capital: Divi’s Labs’ Growth Momentum Continues In Q2, More Capex To Meet Demand
Tablets pass through a blister pack packaging machine inside a pharmaceutical laboratories a(Photographer: Martin Leissl/Bloomberg)

Dolat Capital: Divi’s Labs’ Growth Momentum Continues In Q2, More Capex To Meet Demand

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.